Gamma interferon (IFN-y) affects tryptophan metabolism by mediating the expression of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase. In the present study, we investigated the role of indoleamine 2,3-dioxygenase-mediated tryptophan depletion in the induction of tryptophanyl-tRNA synthetase by IFN--y. The addition of excess tryptophan to the culture medium did not affect the induction of tryptophanyl-tRNA synthetase by IFN-y, indicating that tryptophan degradation is not directly involved in the IFN-y-mediated expression of tryptophanyl-tRNA synthetase.
Gamma interferon (IFN--y), a cytokine produced primarily by T lymphocytes and natural killer cells, plays an important role in immunological responses, regulation of cell growth, and host cell defense mechanisms against intracellular parasites (for a review, see references 10, 11, 22, and 31) . In particular, IFN--y has potent growth-inhibitory effects on Toxoplasma gondii and Chlamydia spp., such as C. psittaci and C. trachomatis. The growth-inhibitory effect of IFN--y on T. gondii and Chlamydia spp. has been attributed to the intracellular depletion of tryptophan by the IFN--y-induced expression of indoleamine 2,3-dioxygenase (IDO) (4, 6, (23) (24) (25) . IDO is a hemoprotein that decyclizes tryptophan to N-formylkynurenine by catalyzing the incorporation of superoxide anion or molecular oxygen into the pyrrole ring of tryptophan, a step that results in the rapid depletion of intracellular tryptophan (29) . The growth-inhibitory effect of IFN-y on intracellular parasites can be largely overcome by the addition of excess tryptophan to the growth medium (4, 6, (23) (24) (25) . Similarly, the antiproliferative effect of IFN-y on a number of tumor cells also appears to be due in part to the enhanced catabolism of tryptophan by IFN--y-induced IDO expression (9, 12, 21, 30) . We and others recently described the cloning of a novel interferon-induced protein (3, 13, 27) , termed IFP53 on the basis of its molecular weight. IFP53 exhibits high sequence homology to rabbit peptide chain release factor (18) and mammalian tryptophanyl-tRNA synthetases (14, 15) . Functional analysis of a cloned fusion protein revealed that IFP53 represents the human tryptophanyl-tRNA synthetase (1) . IDO expression and IFP53 expression are induced in many cell types, including human HeLa cells, strongly by IFN--y but rather weakly by IFN-a or IFN-P (3, 5, 7, 9, 13, 27, 30; unpublished data).
The regulation of the biosynthesis of aminoacyl-tRNA synthetases in prokaryotes has been extensively studied (19, 20) . Early experiments indicated the involvement of the cognate amino acid in the control of aminoacyl-tRNA synthetase expression; i.e., upon amino acid restriction, the cognate aminoacyl-tRNA synthetase exhibits derepression. Concerning the regulation of mammalian tRNA synthetases, * Corresponding author.
selective derepression upon restriction of the cognate amino acid has been described (16, 17) .
The intracellular depletion of L-tryptophan by the IFN--ymediated expression of IDO, the simultaneous induction of IFP53/tryptophanyl-tRNA synthetase and the reported involvement of the cognate amino acid in the control of aminoacyl-tRNA synthetases prompted us to investigate the effect of exogenously added tryptophan on IFN--y-mediated IFP53/tryptophanyl-tRNA synthetase expression.
HeLa cells were grown as monolayer cultures in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum. Treatment of human HeLa cells with IFN--y (Polyferon at 2 x 107 U/mg of protein; Rentschler, Laupheim, Germany) results in the increased expression of IDO (5, 9, 30; see Fig. 1 and 2). To determine the effect of exogenous tryptophan (Sigma, Deisenhofen, Germany) on the IFN--ymediated expression of IFP53, we added the two components simultaneously to cells grown to subconfluence at concentrations of 50, 100, and 500 U of IFN-y per ml and 50 and 250 ,g of tryptophan per ml. These doses of tryptophan have been shown to reverse completely the growth-inhibitory action of IFN--y on intracellular parasites (4, 6, 23, 24) as well as to rescue human tumor cells from the antiproliferative effect of IFN--y (9, 21, 30) .
During the course of tryptophan addition in conjunction with IFN--y treatment, the specific activity of tryptophanyltRNA synthetase as well as IFP53 mRNA expression was determined. Total cellular RNA was prepared by the guanidinium isothiocyanate procedure (28) and purified by centrifugation through cesium chloride. RNA (7.5 ,ug) was electrophoresed on formaldehyde gels and transferred to nitrocellulose, and Northern (RNA) blotting was performed by standard procedures (28) . Quantitative loading of RNA was determined by staining with ethidium bromide and by hybridization to a pyruvate kinase probe (2). A 1.3-kb EcoRI fragment from clone 9.2 (3) was used as a hybridization probe for IFP53; for 9.27 (see below), a 260-bp EcoRI cDNA fragment was used (26) . The probe for IDO was generated by amplification of a 760-bp fragment by use of specific oligonucleotides (8). Treatment with 50, 100, and 500 U of IFN--y per ml resulted in a significant increase in IFP53, 9.27, and IDO mRNA expression ( Fig. 1 and 2 ml-7 mg of total yeast tRNA per ml-8 mM ATP-0.1 mM L-['4C]tryptophan (54 mCi/mmol; Amersham). At various times, 9-,u aliquots from a 60-pul reaction mixture were removed, spotted on a Whatman GFC disk, and immediately precipitated with trichloroacetic acid, and the radioactivity retained on the filters was counted. The levels of IFN-yinduced tryptophanyl-tRNA synthetase activity were not affected by exogenous tryptophan (Fig. 3) .
Our data indicate that the depletion of intracellular tryptophan is not directly involved in the IFN--y-mediated expression of tryptophanyl-tRNA synthetase. It is, however, unlikely that the IFN-y-induced degradation of tryptophan and the induction of tryptophanyl-tRNA synthetase by IFN-y are unrelated events. Linking of these two events is probably advantageous for host cells with respect to defense mechanisms against intracellular parasites. The induction of IDO by IFN--y leads to starvation of the cells for an essential amino acid. T. gondii and Chlamydia spp., like host cells, are incapable of tryptophan synthesis (23) . As free tryptophan but not tryptophanylated tRNA is accessible to intracellular parasites, the induction of tryptophanyl-tRNA synthetase may represent a mechanism for rendering residual tryptophan accessible for host cell protein synthesis to the exclusion of the parasite.
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